Massar Capital Management, LP

Position in ALKS — Alkermes plc.

CIK 2037238 STAMFORD, CT

Position in ALKS

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,362,924

New position

Shares Held

26,010

first reported quarter

Ownership

0.016%

of shares outstanding

% of Portfolio

0.54%

of 13F equity value

Holder Rank

#196

of 421 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Massar Capital Management, LP holds $8,768,387 across 6 Drug Manufacturers - Specialty & Generic names. ALKS ranks #3 (15.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	UTHR	UNITED THERAPEUTICS Corp	8,055	$4,364,440
2	LQDA	Liquidia Corp	27,797	$2,216,254
3	ALKS	Alkermes plc. This page	26,010	$1,362,924
4	ZTS	Zoetis Inc.	8,175	$587,455
5	HROW	Harrow, Inc.	5,110	$217,021
6	AKBA	Akebia Therapeutics, Inc.	17,801	$20,293

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,362,924	26,010	—	Shares	Sole	2026-08-14
No filing history on record for this holder in this stock.